(Q41134938)

27 September 2017

1 reference

title

Experimental spondyloarthropathy in HLA-B27 transgenic rats (English)

1 reference

27 September 2017

J D Taurog

1

1 reference

27 September 2017

R E Hammer

series ordinal

2

1 reference

27 September 2017

publication date

1 January 1996

1 reference

27 September 2017

published in

Clinical Rheumatology

1 reference

27 September 2017

volume

15 Suppl 1

1 reference

27 September 2017

page(s)

22-27

1 reference

The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03342640

Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03342640

The distribution of Tap2 alleles among laboratory rat RT1 haplotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03342640

Identification of self peptides bound to purified HLA-B27

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03342640

Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression.

21 January 2018

1 reference

12 December 2020

A prospective study of patients with spondyloarthropathy with special reference to HLA-B27 and to gut histology.

1 reference

12 December 2020

Spontaneous intestinal inflammation and nitric oxide metabolism in HLA-B27 transgenic rats

1 reference

12 December 2020

[Fusion of vertebrae and the sacroiliac joint by cartilaginous tissue in HLA-B27 transgenic rats]

1 reference

12 December 2020

Characterization of psoriasiform and alopecic skin lesions in HLA-B27 transgenic rats

1 reference

12 December 2020

Rat MHC-linked peptide transporter alleles strongly influence peptide binding by HLA-B27 but not B27-associated inflammatory disease.

1 reference

12 December 2020

T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats.

1 reference

12 December 2020

High prevalence of colorectal cancer in HLA-B27 transgenic F344 rats with chronic inflammatory bowel disease.

1 reference

12 December 2020

In vitro mutagenesis of HLA-B27. Amino acid substitutions at position 67 disrupt anti-B27 monoclonal antibody binding in direct relation to the size of the substituted side chain

1 reference

12 December 2020

Sharing of an HLA-B27-restricted H-Y antigen between rat and mouse

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03342640

1 reference

27 September 2017

1 reference